Clinical Trial Update: Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment

View source ↗

Summary

This clinical trial evaluating cytokines and acute phase reactants as markers of pulmonary tuberculosis treatment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: Pulmonary Tuberculosis | Status: WITHDRAWN